Biopsy Devices | Market Insights | US | 2022
The COVID-19 pandemic will have a negative impact on the US biopsy device market in the short term. Once the market stabilizes, however, biopsy procedure volumes will continue to grow marginally through 2030, driven by favorable demographic trends, the development of more accurate testing methods, improved imaging technologies, as well as updated recommendations to screening guidelines.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in the US across an 11-year period.
